Applications of kidney organoids derived from human pluripotent stem cells.
- Author:
Yong Kyun KIM
1
;
Sun Ah NAM
;
Chul Woo YANG
Author Information
- Publication Type:Review
- Keywords: Bioprinting; Clustered regularly interspaced short palindromic repeats; Kidney; Organoids; Transplantation
- MeSH: Bioprinting; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Evaluation, Preclinical; Genome; Humans*; Kidney Diseases; Kidney*; Organoids*; Pluripotent Stem Cells*; Regenerative Medicine; Transplantation
- From:The Korean Journal of Internal Medicine 2018;33(4):649-659
- CountryRepublic of Korea
- Language:English
- Abstract: The establishment of protocols to differentiate kidney organoids from human pluripotent stem cells provides potential applications of kidney organoids in regenerative medicine. Modeling of renal diseases, drug screening, nephrotoxicity testing of compounds, and regenerative therapy are attractive applications. Although much progress still remains to be made in the development of kidney organoids, recent advances in clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated system 9 (Cas9) genome editing and three-dimensional bioprinting technologies have contributed to the application of kidney organoids in clinical fields. In this section, we review recent advances in the applications of kidney organoids to kidney disease modelling, drug screening, nephrotoxicity testing, and regenerative therapy.
